Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis

Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis

Item
http://www.wikidata.org/entity/Q28190416
Insights into the complex formed by matrix metalloproteinase-2 and alloxan inhibitors: molecular dynamics simulations and free energy calculationsMatrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis.Matrix metalloproteinase inhibitors in rheumatic diseases.MMP-1 drives immunopathology in human tuberculosis and transgenic mice.Matrix metalloproteinase inhibitors for cancer therapy:the current situation and future prospects.Proteinases in the joint: clinical relevance of proteinases in joint destructionTuberculosis immunopathology: the neglected role of extracellular matrix destruction.Metalloproteases as potential therapeutic targets in arthritis treatment.On the origin of the catalytic power of carboxypeptidase A and other metalloenzymes.Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis.One-pot synthesis of GABA amides via the nucleophilic addition of amines to 3,3-disubstituted cyclopropenes.Host-Directed Therapies for Tuberculosis.Challenges to develop novel anti-inflammatory and analgesic drugs.Synovial fluid proteomics in the pursuit of arthritis mediators: An evolving field of novel biomarker discovery.Separately tackling the development of erosions with denosumab: ultimately closing a gap in the treatment of patients with rheumatoid arthritis or trying too hard too late?Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis
P2860

Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis

Item
http://www.wikidata.org/entity/Q28190416
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Tolerability and pharmacokinet ...... ents with rheumatoid arthritis
@ast
Tolerability and pharmacokinet ...... ents with rheumatoid arthritis
@en
Tolerability and pharmacokinet ...... ents with rheumatoid arthritis
@nl
type
label
Tolerability and pharmacokinet ...... ents with rheumatoid arthritis
@ast
Tolerability and pharmacokinet ...... ents with rheumatoid arthritis
@en
Tolerability and pharmacokinet ...... ents with rheumatoid arthritis
@nl
prefLabel
Tolerability and pharmacokinet ...... ents with rheumatoid arthritis
@ast
Tolerability and pharmacokinet ...... ents with rheumatoid arthritis
@en
Tolerability and pharmacokinet ...... ents with rheumatoid arthritis
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Tolerability and pharmacokinet ...... ents with rheumatoid arthritis
@en
P2093
P2860
P304
P31
P356
10.1093/RHEUMATOLOGY/40.5.537
P407
P433
P478
P577
P698
P921